Tech Company Financing Transactions
Dimension Therapeutics Funding Round
Dimension Therapeutics, operating out of Cambridge, scored $5 million from F-Prime Capital and private investors.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
F-Prime Capital (Benjamin Auspitz)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Drive
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Dimension Therapeutics, Inc., is a leading rare disease company focused on developing novel treatments for devastating disorders associated with the liver and based on an industry-leading, extensively validated adeno-associated virus (AAV) platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Annalisa Jenkins
Chief Financial Officer
Jean Franchi
Chief Medical Officer
Eric Crombez
Chief Scientific Officer
Sam Wadsworth
VP - Bus. Development
Andy Hu
VP - Human Resources
Rachel Strauss
VP - Manufacturing
Reed Clark
VP - Operations
Stephanie Haller
VP - Regulatory Affairs
Khandan Baradaran
Browse more venture capital transactions:
Prev: 12/31/2013: Molecule Software venture capital transaction
Next: 12/31/2013: Appthority venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs